MedTrace Logo

Ambroxol Spray Sore Throat Study

NCT01361802 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 494

Last updated 2014-05-16

No results posted yet for this study

Summary

The development of a new Ambroxol spray formulation for the treatment of sore throat pain associated with acute pharyngitis requires an initial phase II study to be conducted in order to select the most appropriate dose for pain relief.

Conditions

Interventions

DRUG

Ambroxol Spray

low dose Ambroxol Spray

DRUG

Ambroxol Spray

medium dose Ambroxol Spray

DRUG

Ambroxol Spray

high dose Ambroxol Spray

DRUG

Placebo Spray

Placebo Spray

Sponsors & Collaborators

Principal Investigators

  • Boehringer Ingelheim · Boehringer Ingelheim

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2011-08-31

Countries

  • South Africa

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01361802 on ClinicalTrials.gov